PharmGen Science, Inc. (KRX:004720)

PharmGen Science Revenue

PharmGen Science had revenue of 42.88B KRW in the quarter ending March 31, 2025, with 0.87% growth. This brings the company's total for the last twelve months to 171.66B, down -0.02% year-over-year. In the year 2024, PharmGen Science had annual revenue of 171.29B with 2.70% growth. That makes PharmGen Science the 20,852nd largest company in the world by revenue and 1,121st in South Korea.

• Revenue (ttm): 171.66B
• Revenue Growth: -0.02%
• P/S Ratio: 0.38
• Revenue / Employee: 759.55M
• Employees: 226
• Market Cap: 64.78B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• South Korea 170.61B 99.6%
• Overseas 677.68M 0.4%

Fiscal year ended Dec 31, 2024 See the full PharmGen Science breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	171.29B	4.51B	2.70%
Dec 31, 2023	166.78B	15.85B	10.50%
Dec 31, 2022	150.93B	41.06B	37.38%
Dec 31, 2021	109.87B	13.25B	13.72%
Dec 31, 2020	96.61B	1.48B	1.55%

Data Source: S&P Global Market Intelligence Last updated: May 15, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error